News

Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies

HACKENSACK, NJ / ACCESSWIRE / August 1, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global preclinical and clinical research…

1 year ago

Jaguar Health Announces FDA Activation of Third-Party Investigational New Drug (IND) Application for Evaluation of Crofelemer for Treatment of Uncontrolled Diarrhea in Patient with Short Bowel Syndrome (SBS)

Napo Pharmaceuticals, a Jaguar Health company and the manufacturer of crofelemer, is supporting this physician-generated INDSAN FRANCISCO, CA / ACCESSWIRE…

1 year ago

iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for the Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory Technology

iTOL-100 technology has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of…

1 year ago

CureVac Announces Dosing of First Participant in Phase 2 Study of Modified COVID-19 mRNA Vaccine Candidates Developed in Collaboration with GSK

Phase 2 study initiated at clinical sites in Australia with monovalent and bivalent mRNA COVID-19 vaccine candidatesVaccine candidates developed in…

1 year ago

Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023

Revenue growth and customer pipeline advance the Company towards breakevenNEW HAVEN, Conn., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Specialty cancer…

1 year ago

SciSparc and Clearmind Collaboration Continues to Increase its Patent Portfolio in the Field of Movement Abnormalities in the U.S.

TEL AVIV, Israel, Aug. 01, 2023 (GLOBE NEWSWIRE) -- The new U.S. patent application is for the use of the…

1 year ago

Privia Health to Enter Washington State

ARLINGTON, Va., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) a national physician enablement company, announced…

1 year ago

Clearmind Medicine Files Patent Application with USPTO for the Treatment of Dyskinesia; Further Strengthens its Already Robust IP Portfolio

Tel Aviv, Israel / Vancouver, Canada, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE:…

1 year ago

Outlook Therapeutics® to Present at the BTIG Virtual Biotechnology Conference 2023

Live webcast fireside chat on Monday, August 7th at 1:00 PM ETISELIN, N.J., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Outlook…

1 year ago

TerrAscend Preannounces Strong Second Quarter 2023 Revenue and Gross Margins and Provides Full Year Guidance

Record second quarter 2023 Net Revenue of $72.1 million, up 12.7% year-over-year and 3.9% sequentially, representing the 7th consecutive quarter…

1 year ago